Transplant Biomedicals Announces Positive Interim Results of the First in Human Clinical Study of VIVIAN® Device in Kidney Transplantation (the EMERGE Study)
Transplant Biomedicals, a company specializing in the research and development of medical devices for organ, tissue and cell preservation, today announces the positive interim results at 30-days post-transplantation of the first-in-human clinical trial of VIVIAN® KIDNEY, a medical device used... - June 23, 2019
Press Releases 1 - 1 of 1